Press release
Non-alcoholic Steatohepatitis (NASH) Biomarkers Market CAGR Projected to Grow at 31.7% through 2024
Global NASH Biomarkers Market: SnapshotNon-alcoholic Steatohepatitis (NASH) is a degenerative form of non-alcoholic fatty liver disease (NAFLD) that leads to damage and inflammation over time. The unwanted fat deposition in liver is the main cause of this disease. If left untreated or undiagnosed, it can lead to liver cirrhosis and eventually progress to liver failure. The high prevalence of liver-related diseases has coaxed several industry players and research institutes to invest in development of sophisticated NASH diagnostic and therapeutic products. Owing to these reasons, the global NASH biomarkers is expected to reach a valuation of US$1.7 bn by the end of 2024 from US$201.2 mn in 2016. During the forecast period of 2016 and 2024, the global market is estimated to progress at a CAGR of 31.7%.
Increasing Number of Type 2 Diabetics to Augment Demand for NASH Biomarkers
Currently, histopathology using a liver biopsy which is an invasive method, imaging techniques like magnetic resonance imaging (MRI), transient Elastography (TE), ultrasound, etc., and in vitro diagnostic techniques using some biomarkers are used for diagnosing and monitoring NASH. However, the introduction of biomarkers has given the patients the option of non-invasive methods for understanding the stage and development of the disease. This precise factor is estimated to boost the market’s growth in the coming years.
Obtain Report Details @ https://www.transparencymarketresearch.com/non-alcoholic-steatohepatitis-biomarkers-market.html
Analysts anticipate that the global market will also be driven by the huge untapped need for diagnosing NASH. Furthermore, the growing number of type 2 diabetics are also expected to augment the demand for NASH biomarkers as they are prone to liver-related diseases. Changing lifestyles and improving healthcare expenditure is also likely to make a significant difference to the soaring revenue of the overall market.
Serum Biomarkers to Lead the Pack during Forecast Period
On the basis of type, the global NASH biomarkers market is segmented into serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, and oxidative stress biomarkers. Of these, serum biomarkers and hepatic biomarkers are extensively used in the medical field. The serum biomarkers are expected to lead the global market due to ability to deliver efficient results.
Apoptosis markers follow this lead closely. In terms of end users, the global NASH biomarkers market is segmented into CRO and pharmaceutical industries, academic research institutes, hospitals, and diagnostic laboratories. The report suggests that hospitals and diagnostic laboratories are likely to dominate the global market in the coming years. The increasing demand for non-invasive NASH diagnostic and monitoring tools in the ongoing trials by CRO and pharmaceutical manufacturers are expected to boost the share of the respective segment over the forecast period as well.
Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18650
Increasing Number of Patients with NAFLD and NASH keep Europe in Lead
In terms of geography, the global NASH biomarkers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Presently, Europe leads the pack due to the strong presence of players in the region. The report states that Europe will continue to dominate the global market due to the increasing pool of population suffering from NAFLD and NASH. Over the same period, North America will also show steady demand for NASH biomarkers due to its well-established healthcare industry and a huge population base.
The key players operating in the global NASH biomarkers market are Genfit SA, One Way Liver S.L., BioPredictive S.A.S, Siemens Heathcare Pvt. Ltd. (now Siemens Healthineers), Exalenz Biosciences Ltd., Prometheus Laboratories Corp. (part of Nestle Health Sciences), Quest Diagnostic Incorporated, and SNIBE diagnostics.
Enquiry for Discount on this Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=18650
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-alcoholic Steatohepatitis (NASH) Biomarkers Market CAGR Projected to Grow at 31.7% through 2024 here
News-ID: 1136616 • Views: …
More Releases from Transparency Market Research
Global Ophthalmic Sutures Market to Reach USD 1.3 Billion by 2034, Driven by Ris …
The global Ophthalmic Sutures Market is experiencing significant momentum as demand surges for improved ophthalmic surgical outcomes amid increasing incidences of ocular disorders worldwide. According to the latest industry assessment, the market, valued at US$ 629.0 million in 2023, is projected to expand at a CAGR of 6.5% between 2024 and 2034, ultimately reaching US$ 1.3 billion by 2034.
This comprehensive press release provides an in-depth examination of market size, trends,…
Global Ophthalmology PACS Market to Reach USD 359.8 Mn by 2034, Driven by Rising …
The global Ophthalmology PACS (Picture Archiving and Communication System) Market is poised for strong expansion over the next decade as the industry continues transitioning toward digital, AI-enabled ophthalmic imaging management solutions. According to recent market assessments, the global Ophthalmology PACS market valued at US$ 167.8 Mn in 2023 is projected to grow at a CAGR of 7.3% from 2024 to 2034, ultimately reaching US$ 359.8 Mn by the end of…
Global Ophthalmology Surgical Devices Market Set to Reach USD 12.1 Billion by 20 …
The global Ophthalmology Surgical Devices Market is poised for steady expansion, driven by rising demand for advanced surgical systems, increasing prevalence of cataracts and glaucoma, and accelerating adoption of minimally invasive techniques. The market was valued at US$ 8.1 billion in 2022 and is projected to reach US$ 12.1 billion by 2031, expanding at a CAGR of 4.7% from 2023 to 2031.
Unlock crucial data and key findings from our Report…
Global Opioid Use Disorders Market to Reach US$ 8.8 Billion by 2034, Driven by R …
The global Opioid Use Disorders (OUD) Market is set for strong expansion over the next decade, rising from US$ 3.2 billion in 2023 to an estimated US$ 8.8 billion by 2034, according to the latest industry assessment. The market is projected to grow at a CAGR of 9.9% from 2024 to 2034, supported by increasing government funding, rising public awareness, and the escalating prevalence of opioid addiction across all major…
More Releases for NASH
The Growing Demand For NASH Treatment Amid Obesity Epidemic: A Key Catalyst Acce …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Non-Alcoholic Steatohepatitis (NASH) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for non-alcoholic steatohepatitis (NASH) has seen a considerable expansion in the past few years. Its value is expected to rise from $4.5 billion in 2024 to $6.06 billion in 2025, marking…
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
